Ofloxacine Unit Dose Stulln (Ofloxacin)

Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition stops bacterial cell division, leading to bacterial death and clearance of the infection from the ocular surface.

The dosing regimen for Ofloxacine Unit Dose Stulln is determined by the prescribing clinician based on the severity of the infection, patient age, and response to therapy. The prescriber will specify the number of drops, frequency, and duration of treatment.

Safety data for ofloxacin ophthalmic use in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ofloxacine (ofloxacin) belongs to the fluoroquinolone class, offering broad‑spectrum coverage against Gram‑negative and some Gram‑positive bacteria. Compared with older agents like chloramphenicol, it provides higher potency and a lower risk of resistance, but like all fluoroquinolones, it requires careful use to avoid rare serious adverse events.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the unit‑dose vials in their original packaging, protect them from light, and avoid exposure to moisture. Do not freeze the product.

The solution is applied topically to the affected eye(s) as directed by the prescriber. Typically, one drop is placed in the conjunctival sac of the infected eye(s) at the prescribed frequency, ensuring the eyelids are gently closed after instillation to allow absorption.

Serious risks, though rare, include severe allergic reactions (e.g., swelling, rash, or hives), corneal ulceration, significant ocular inflammation, and potential vision loss. Patients should discontinue use and seek immediate medical attention if any of these symptoms occur.

Individuals with a known hypersensitivity to ofloxacin, other fluoroquinolones, or any component of the formulation should avoid using this product. It is also contraindicated in viral or fungal eye infections, as it will not be effective and may worsen the condition.